Rhinocort Turbuhaler and Tecentriq

• Generic Name: budesonide
• Dosage Forms: n.a.
• Other Brand Names: Entocort EC, Uceris, Pulmicort Flexhaler, Pulmicort Respules

Budesonide is used to help prevent the symptoms of asthma. When used regularly every day, inhaled budesonide decreases the number and severity of asthma attacks. However, it will not relieve an asthma attack that has already started.

Budesonide is a corticosteroid or steroid (cortisone-like medicine). It works by preventing inflammation (swelling) in the lungs, which makes the asthma attack less severe. Inhaled budesonide may be used with other asthma medicines such as bronchodilators, which are also used to open up narrowed breathing passages in the lungs.

This medicine is available only with your doctor's prescription.

• Generic Name: atezolizumab
• Dosage Forms: injection, solution
• Other Brand Names: Tecentriq

Tecentriq (atezolizumab) is a monoclonal antibody that affects the actions of the body's immune system. Atezolizumab strengthens your immune system to help your body fight against tumor cells.

Tecentriq is used to treat a certain type of bladder cancer and urinary tract cancer that has spread to other parts of the body or cannot be removed by surgery.

Your doctor may perform a biopsy to test your cancer for a protein called "PD-L1," or a specific genetic marker (an abnormal "EGFR" or "ALK" gene).

Tecentriq is used to treat non-small cell lung cancer that has spread to other parts of the body or cannot be removed by surgery.

Tecentriq is used in combination with the medicine paclitaxel protein-bound to treat a type of breast cancer called triple-negative breast cancer (TNBC) that has spread to other parts of the body or cannot be removed by surgery, and tests positive for “PD-L1", or a specific genetic marker (an abnormal "EGFR" or "ALK" gene).

Tecentriq is also used to treat a type of lung cancer called small cell lung cancer (SCLC).

Tecentriq is sometimes given after other cancer treatments have not worked or have stopped working.